Loading…
Attending this event?
Back To Schedule
Wednesday, October 26 • 9:00am - 9:30am
Keynote: Assessing the Financial Value of Decentralized Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • We developed a risk-adjusted discounted cash flow model (expected net present value) to measure the net financial benefit of decentralized clinical trials (DCTs)
  • Benchmark development data indicate that DCTs provide benefits from shorter clinical phase cycle times, reduced screen failure rates, and fewer substantial protocol amendments
  • This pilot study found a nearly five-fold return on investment (ROI) if DCT methods are applied to all phase II trials, a 13-fold ROI if applied to all phase III trials, and nearly a seven-fold ROI if applied to both phase II and phase III trials

Speakers
avatar for Joseph DiMasi, PhD

Joseph DiMasi, PhD

Director of Economic Analysis, Tufts University


Wednesday October 26, 2022 9:00am - 9:30am EDT